cesarean section. Complication of labor and delivery
Conditions
Interventions
Intervention 1: Intervention group: receives 10 mg of marcaine 0.5% (CobelDarou, Tehran) and 80 mg of magnesium sulfate (CobelDarou, Tehran) , intrathecally (in the third, fourth or fourth and fifth
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women without history of bleeding after surgery. Women without allergy to Amide anesthetics. Women without history of heart, liver and renal diseases. Women without history of taking psychedelic drugs. The women with the age of 15 - 45 years. The women without history of smoking. The women without history of coagulation diseases. The women without history of infectious diseases.
Exclusion criteria
Exclusion criteria: Having neuro-muscular disease Use of opioids or painkillers during 3 days before the study Severe obesity (BMI = 35-34) Consumption of calcium channel blockers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: Verbal Analogue Scale method.;Blood pressure. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: Mercury sphygmomanometer.;Hear rate. Timepoint: at 1, 2, 3, 4, 8, 12 postoperative hours. Method of measurement: heart-rate monitors. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mohammad Ebnehejazi
Birjand University of Medical Sciences
Outcome results
None listed